Navigation Links
Acrylamide Won't Raise Breast Cancer Risk

Fried, baked food compound poses no threat, major study finds

TUESDAY, Aug. 21 (HealthDay News) -- There seems to be little or no link between breast cancer and acrylamide, a substance found in many baked and fried foods, according to the largest epidemiological study on the subject conducted to date.

"The data are accumulating, and it appears that acrylamide in the diet does not appear to be an important breast cancer risk factor," said study author Lorelei Mucci, an assistant professor of medicine at Harvard Medical School and an assistant professor of epidemiology at Harvard School of Public Health in Boston.

"We probably couldn't rule out that eating very high levels of acrylamide is associated with a very, very small increase in risk, but in terms of it being an important public health risk factor for breast cancer I don't think acrylamide is a major risk factor," she said.

Mucci plans to present the finding Tuesday at the American Chemical Society annual meeting, in Boston. The paper is one of 40 exploring various facets of a possible association between acrylamide and cancer.

Acrylamide is classified as a "probable" human carcinogen but only based on earlier animal studies in which the animals were exposed to levels of acrylamide up to 100,000 times higher than that normally consumed through foods.

The substance forms naturally during the cooking process of mostly carbohydrate-rich foods such as potato chips, french fries, breads, cereals and even coffee.

Even though the data on human health has remained unclear, food safety authorities in Europe have started to curb acrylamide in foods.

According to the study authors, about 30 percent of calories consumed among U.S. and European populations contain acrylamide. The average adult consumption is 0.5 micrograms per kilogram of body weight per day. Children consume higher levels.

For the current study, Mucci and her colleagues followed a group of 100,000 U.S. nurses over a 20-year period. Participants periodically answered questionnaires about their dietary habits. This information was used to estimate daily acrylamide intake, which was then correlated with breast cancer incidence.

The result: The incidence of breast cancer among women with a high acrylamide intake was about the same as women with low intakes.

That corresponds with findings from a previous study (also by Mucci) of Swedish women that also showed no association between dietary acrylamide and risk of breast cancer. The largest source of dietary acrylamide in U.S. women is french fries, while in Swedish women it is coffee.

The only other published epidemiological study, conducted in Italy, also found no association.

"At the moment, I don't think there is any clear connection between acrylamide and breast cancer," said Shiuan Chen, director and professor of surgical research at City of Hope Cancer Center in Duarte, Calif.

"I thought the results were gratifying," added Robert Tardiff, president of the Sapphire Group and an advisor to the Food Products Association, both in Washington, D.C.

"Here is an example of a situation which caused a great deal of concern based on laboratory studies, and now we have a reasonably definitive study showing that there's no link between acrylamide consumption and breast cancer. So, that's great," he said.

The association found in animal studies could be explained by the high levels of acrylamide they consumed, or by differences in how acrylamide is metabolized in the body, the experts said.

This is not likely to close the door on research into acrylamide, however.

"The food industry has been spending a lot of time and research on how to avoid acrylamide formation in food, and toxicologists are still very interested in looking at acrylamide," Mucci said. "There's also a new animal study with rats and mice looking at very high levels of acrylamide and cancer risk. There's been concern whether acrylamide could have some impact on hormonal levels, so we would want to look at endometrial and ovarian cancer, because they are hormone-driven."

Tardiff added, "One of the issues that we are working on, and that we think is particularly promising, is that there is significant detoxification of acrylamide quickly [in the human body], so it is no longer available at the levels we found in food. That research will be finished in the next couple of months."

Mucci will also be presenting data at the American Chemical Society meeting on prostate cancer and acrylamide (again, her team found no link).

But cancer is not the only reason to avoid certain foods.

"We want to think about our overall health, and there are a lot of reasons to have a low-fat diet and maintain a healthy weight," Mucci pointed out. "Obesity is a risk factor for so many diseases. Eat a sensible diet, don't eat too much of one thing. If you get a diverse diet, you're probably going to be protecting yourself."

"Environmental exposures have a lot of influence on cancer, including breast cancer, and that includes diet," Chen added. "Diversify your diet. Eating french fries once in a while is probably OK, but not three times a day."

More information

The Joint Institute for Food Safety and Applied Nutrition has information on acrylamide.

SOURCES: Lorelei Mucci, Sc.D., assistant professor, medicine, Harvard Medical School and assistant professor, epidemiology, Harvard School of Public Health, Boston; Shiuan Chen, Ph.D., director and professor, department of surgical research, City of Hope Cancer Center, Duarte, Calif.; Robert Tardiff, Ph.D., president, Sapphire Group, and advisor, Food Products Association, Washington, D.C.; Aug. 21, 2007, presentation, American Chemical Society annual meeting, Boston

Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Breast cancer risk not increased by acrylamide
2. Adding Milk to Black Tea Wont Ruin Its Antioxidant Effects
3. Obesity raises IVF miscarriage risk
4. Frequent use of antibiotics raises the risk of carrying resistant infections
5. Heavy Drinking Raises Risk of Liver Cancer
6. Air pollution may raise risk of lung cancer
7. Women are at risk with raised cholesterol
8. Swimming in Chlorinated Pools Raises Asthma Risk
9. Tight necktie may raise glaucoma risk
10. Painkillers may raise miscarriage risk
11. New Treatment To Raise Good Cholesterol
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology: